Panagora Asset Management Inc Precision Biosciences Inc Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $120,548 - $350,115	-104,825 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.96 - $7.76 $223,246 - $585,266	-75,421 Reduced 41.84%	104,825 $323,000
Q4 2021 Feb 10, 2022	BUY	$7.4 - $11.66 $134,805 - $212,410	18,217 Added 11.24%	180,246 $1.33 Million
Q3 2021 Nov 10, 2021	BUY	$9.18 - $14.15 $28,393 - $43,765	3,093 Added 1.95%	162,029 $1.87 Million
Q2 2021 Aug 11, 2021	BUY	$8.07 - $12.52 $1.13 Million - $1.75 Million	139,726 Added 727.36%	158,936 $1.99 Million
Q4 2020 Feb 10, 2021	BUY	$5.98 - $12.47 $3,952 - $8,242	661 Added 3.56%	19,210 $160,000
Q2 2020 Aug 12, 2020	SELL	$4.66 - $8.7 $2,823 - $5,272	-606 Reduced 3.16%	18,549 $155,000
Q1 2020 May 14, 2020	BUY	$5.05 - $15.01 $93,672 - $278,420	18,549 Added 3060.89%	19,155 $116,000
Q3 2019 Nov 12, 2019	BUY	$8.03 - $14.82 $4,866 - $8,980	606 New	606 $5,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.